Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-16-006205
Filing Date
2016-05-11
Accepted
2016-05-11 12:27:34
Documents
34
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUATERLY REPORT proteo_10q-033116.htm 10-Q 224808
2 CERTIFICATION proteo_10q-ex3101.htm EX-31.1 9347
3 CERTIFICATION proteo_10q-ex3102.htm EX-31.2 9434
4 CERTIFICATION proteo_10q-ex32.htm EX-32 5610
  Complete submission text file 0001019687-16-006205.txt   935689

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20160331.xml EX-101.INS 77823
6 XBRL SCHEMA FILE pteo-20160331.xsd EX-101.SCH 11084
7 XBRL CALCULATION FILE pteo-20160331_cal.xml EX-101.CAL 26902
8 XBRL DEFINITION FILE pteo-20160331_def.xml EX-101.DEF 8858
9 XBRL LABEL FILE pteo-20160331_lab.xml EX-101.LAB 82434
10 XBRL PRESENTATION FILE pteo-20160331_pre.xml EX-101.PRE 61639
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

EIN.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 161639030
SIC: 2834 Pharmaceutical Preparations